Last 12 months
Inside the activity.
0 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 04, 2024 Filed Jan 8, 2024 21:39 UTC |
Silberman DavidChief Financial Officer
|
GrantCommon Stock | 136,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-001146 · doc4.xml · nonDerivative · entry 1 Silberman David · CIK 0001867998 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 366,500 F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 11,375 over a three year period starting January 8, 2024. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 21:37 UTC |
Sank LeonardDirector
|
GrantCommon Stock | 9,325 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-001143 · doc4.xml · nonDerivative · entry 2 Sank Leonard · CIK 0001416089 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,021 F2 · price: Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 2,331 on April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 21:37 UTC |
Sank LeonardDirector
|
GrantCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-001143 · doc4.xml · nonDerivative · entry 1 Sank Leonard · CIK 0001416089 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,696 F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 10,000 shall vest on each of January 1, 2025, January 1, 2026 and January 1, 2027. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 21:36 UTC |
Rozov YadinDirector
|
GrantCommon Stock | 8,820 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-001141 · doc4.xml · nonDerivative · entry 2 Rozov Yadin · CIK 0001921268 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,320 F2 · price: Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of 2,205 on April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 21:36 UTC |
Rozov YadinDirector
|
GrantCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-001141 · doc4.xml · nonDerivative · entry 1 Rozov Yadin · CIK 0001921268 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,500 F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 10,000 shall vest on each of January 1, 2025, January 1, 2026 and January 1, 2027. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 21:34 UTC |
Mayer ArieDirector
|
GrantCommon Stock | 9,325 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-001137 · doc4.xml · nonDerivative · entry 2 Mayer Arie · CIK 0001796583 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,134 F2 · price: Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 2,331 on April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 21:34 UTC |
Mayer ArieDirector
|
GrantCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-001137 · doc4.xml · nonDerivative · entry 1 Mayer Arie · CIK 0001796583 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,809 F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 10,000 shall vest on each of January 1, 2025, January 1, 2026 and January 1, 2027. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 21:33 UTC |
Aghion DanielDirector
|
GrantCommon Stock | 5,070 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-001135 · doc4.xml · nonDerivative · entry 2 Aghion Daniel · CIK 0002004805 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,070 F2 · price: Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 1,267 on April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 21:33 UTC |
Aghion DanielDirector
|
GrantCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-001135 · doc4.xml · nonDerivative · entry 1 Aghion Daniel · CIK 0002004805 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 10,000 shall vest on each of January 1, 2025, January 1, 2026 and January 1, 2027. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 21:32 UTC |
Shapiro BenjaminDirector
|
GrantCommon Stock | 5,070 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-001131 · doc4.xml · nonDerivative · entry 2 Shapiro Benjamin · CIK 0001974846 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,070 F2 · price: Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 1,267 on April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 21:32 UTC |
Shapiro BenjaminDirector
|
GrantCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-001131 · doc4.xml · nonDerivative · entry 1 Shapiro Benjamin · CIK 0001974846 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 10,000 shall vest on each of January 1, 2025, January 1, 2026 and January 1, 2027. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. Read SEC document |
| May 26, 2023 Filed May 31, 2023 21:10 UTC |
KIDRON NADAVDirector · President and CEO
|
GrantCommon Stock | 120,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-033145 · doc4.xml · nonDerivative · entry 1 KIDRON NADAV · CIK 0001351779 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,452,098 F1 · price: Restricted Stock Units ("RSUs") granted in April 2023 and vested upon achievement of certain performance conditions. The RSUs converted into Issuer's common stock on a one-for-one basis. Read SEC document |
| May 26, 2023 Filed May 31, 2023 21:10 UTC |
Kidron MiriamDirector · Chief Scientific Officer
|
GrantCommon Stock | 53,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-033143 · doc4.xml · nonDerivative · entry 1 Kidron Miriam · CIK 0001409232 · Director · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 468,166 F1 · price: Restricted Stock Units ("RSUs") granted in April 2023 and vested upon achievement of certain performance conditions. The RSUs converted into Issuer's common stock on a one-for-one basis. Read SEC document |
| May 26, 2023 Filed May 31, 2023 21:10 UTC |
Derovan NetanelChief Legal Officer
|
GrantCommon Stock | 20,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-033144 · doc4.xml · nonDerivative · entry 1 Derovan Netanel · CIK 0001901330 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,500 F1 · price: Restricted Stock Units ("RSUs") granted in April 2023 and vested upon achievement of certain performance conditions. The RSUs converted into Issuer's common stock on a one-for-one basis. Read SEC document |
| May 26, 2023 Filed May 31, 2023 21:10 UTC |
Hexter JoshuaCOO & CBO
|
GrantCommon Stock | 27,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-033142 · doc4.xml · nonDerivative · entry 1 Hexter Joshua · CIK 0001573235 · COO & CBO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 301,333 F1 · price: Restricted Stock Units ("RSUs") granted in April 2023 and vested upon achievement of certain performance conditions. The RSUs converted into Issuer's common stock on a one-for-one basis. Read SEC document |
| May 26, 2023 Filed May 31, 2023 21:10 UTC |
Silberman DavidChief Financial Officer
|
GrantCommon Stock | 24,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-033141 · doc4.xml · nonDerivative · entry 1 Silberman David · CIK 0001867998 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,000 F1 · price: Restricted Stock Units ("RSUs") granted in April 2023 and vested upon achievement of certain performance conditions. The RSUs converted into Issuer's common stock on a one-for-one basis. Read SEC document |
| May 01, 2023 Filed May 1, 2023 21:12 UTC |
Shapiro BenjaminDirector
|
GrantCommon Stock | 20,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-026306 · doc4.xml · nonDerivative · entry 1 Shapiro Benjamin · CIK 0001974846 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 1,666 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. Read SEC document |
| April 17, 2023 Filed Apr 20, 2023 10:00 UTC |
Sank LeonardDirector
|
GrantCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-024942 · doc4.xml · nonDerivative · entry 1 Sank Leonard · CIK 0001416089 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,696 F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 2,500 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. Read SEC document |
| April 17, 2023 Filed Apr 20, 2023 10:00 UTC |
Derovan NetanelChief Legal Officer
|
GrantCommon Stock | 81,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-024941 · doc4.xml · nonDerivative · entry 1 Derovan Netanel · CIK 0001901330 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,000 F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 6,750 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. Read SEC document |
| April 17, 2023 Filed Apr 20, 2023 10:00 UTC |
Hexter JoshuaCOO & CBO
|
GrantCommon Stock | 108,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-024940 · doc4.xml · nonDerivative · entry 1 Hexter Joshua · CIK 0001573235 · COO & CBO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 274,333 F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 9,000 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. Read SEC document |
| April 17, 2023 Filed Apr 20, 2023 10:00 UTC |
KIDRON NADAVDirector · President and CEO
|
GrantCommon Stock | 279,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-024939 · doc4.xml · nonDerivative · entry 1 KIDRON NADAV · CIK 0001351779 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,332,098 F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 23,250 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. Read SEC document |
| April 17, 2023 Filed Apr 20, 2023 10:00 UTC |
Rozov YadinDirector
|
GrantCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-024938 · doc4.xml · nonDerivative · entry 1 Rozov Yadin · CIK 0001921268 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,500 F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 2,500 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. Read SEC document |
| April 17, 2023 Filed Apr 20, 2023 10:00 UTC |
Kidron MiriamDirector · Chief Scientific Officer
|
GrantCommon Stock | 213,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-024937 · doc4.xml · nonDerivative · entry 1 Kidron Miriam · CIK 0001409232 · Director · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 414,666 F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 17,750 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. Read SEC document |
| April 17, 2023 Filed Apr 20, 2023 10:00 UTC |
Silberman DavidChief Financial Officer
|
GrantCommon Stock | 97,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-024936 · doc4.xml · nonDerivative · entry 1 Silberman David · CIK 0001867998 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,500 F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 8,125 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. Read SEC document |
| April 17, 2023 Filed Apr 20, 2023 10:00 UTC |
Mayer ArieDirector
|
GrantCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-024935 · doc4.xml · nonDerivative · entry 1 Mayer Arie · CIK 0001796583 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,809 F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 2,500 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. Read SEC document |
| April 04, 2023 Filed Apr 4, 2023 21:10 UTC |
Mayer ArieDirector
|
PurchaseCommon Stock | 3,800 | $2.21 | $8,398.00 |
DisclosureSEC source: 0001209191-23-022815 · doc4.xml · nonDerivative · entry 2 Mayer Arie · CIK 0001796583 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,809 Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 21:10 UTC |
Mayer ArieDirector
|
PurchaseCommon Stock | 5,009 | $2.22 | $11,119.98 |
DisclosureSEC source: 0001209191-23-022815 · doc4.xml · nonDerivative · entry 1 Mayer Arie · CIK 0001796583 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,009 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.17 to $2.22, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the above range. Read SEC document |
| March 16, 2023 Filed Mar 16, 2023 21:10 UTC |
KIDRON NADAVDirector · President and CEO
|
PurchaseCommon Stock | 26,000 | $2.04 | $53,014.00 |
DisclosureSEC source: 0001209191-23-019367 · doc4.xml · nonDerivative · entry 1 KIDRON NADAV · CIK 0001351779 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By wholly-owned corporation Disclosed balance after: 126,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.02 to $2.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the above range. Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 21:25 UTC |
KIDRON NADAVDirector · President and CEO
|
PurchaseCommon Stock | 100,000 | $2.01 | $201,000.00 |
DisclosureSEC source: 0001209191-23-018956 · doc4.xml · nonDerivative · entry 1 KIDRON NADAV · CIK 0001351779 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By wholly-owned corporation Disclosed balance after: 100,000 Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 21:20 UTC |
Kidron MiriamDirector · Chief Scientific Officer
|
SaleCommon Stock | 100,000 | $2.01 | $201,000.00 |
DisclosureSEC source: 0001209191-23-018952 · doc4.xml · nonDerivative · entry 1 Kidron Miriam · CIK 0001409232 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,666 F1 · price: These shares were sold to a company owned solely by Nadav Kidron, a director and the president and chief executive officer of the Issuer, and the Reporting Person used the proceeds in connection with a personal tax payment. Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 21:15 UTC |
Rozov YadinDirector
|
PurchaseCommon Stock | 50,000 | $2.05 | $102,450.00 |
DisclosureSEC source: 0001209191-23-018944 · doc4.xml · nonDerivative · entry 2 Rozov Yadin · CIK 0001921268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,500 F2 · shares: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.00 to $2.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the above range. Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 21:15 UTC |
Rozov YadinDirector
|
PurchaseCommon Stock | 20,000 | $1.96 | $39,120.00 |
DisclosureSEC source: 0001209191-23-018944 · doc4.xml · nonDerivative · entry 1 Rozov Yadin · CIK 0001921268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,500 F1 · shares: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.95 to $1.96, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the above range. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 12:24 UTC |
Rabinowitz MichaelChief Commercial Officer
|
SaleCommon Stock | 11,900 | $12.49 | $148,651.23 |
DisclosureSEC source: 0001209191-23-000517 · doc4.xml · nonDerivative · entry 2 Rabinowitz Michael · CIK 0001876182 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,143 F1 · date: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 7, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.01 to $13.15, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the above range. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 12:24 UTC |
Rabinowitz MichaelChief Commercial Officer
|
SaleCommon Stock | 1,425 | $13.01 | $18,543.81 |
DisclosureSEC source: 0001209191-23-000517 · doc4.xml · nonDerivative · entry 1 Rabinowitz Michael · CIK 0001876182 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,043 F1 · date: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 7, 2022. Read SEC document |
| October 27, 2022 Filed Oct 29, 2022 01:30 UTC |
KIDRON NADAVDirector · President and CEO
|
GiftCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-054879 · doc4.xml · nonDerivative · entry 1 KIDRON NADAV · CIK 0001351779 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,053,098 F1 · price: This transaction represents a charitable donation effective October 27, 2022. This is not a market transaction, thus no price has been reported. No value was received for the donated shares. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:30 UTC |
Sank LeonardDirector
|
Exercise / conversionStock Option · Derivative | 20,000 | $0.00 Strike: $4.08 | $0.00 |
DisclosureSEC source: 0001209191-22-045207 · doc4.xml · derivative · entry 3 Sank Leonard · CIK 0001416089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2022-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options vested as follows: 10,000 vested on each of January 1, 2013 and 2014. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:30 UTC |
Sank LeonardDirector
|
Tax withholdingCommon Stock | 9,304 | $8.77 | $81,596.08 |
DisclosureSEC source: 0001209191-22-045207 · doc4.xml · nonDerivative · entry 2 Sank Leonard · CIK 0001416089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,696 F1 · shares: Represents a cashless exercise of outstanding stock options to purchase 20,000 shares of common stock. The reporting person received 10,696 shares of common stock and surrendered 9,304 shares of common stock underlying the stock option in payment of the exercise price. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:30 UTC |
Sank LeonardDirector
|
Exercise / conversionCommon Stock | 20,000 | $4.08 | $81,600.00 |
DisclosureSEC source: 0001209191-22-045207 · doc4.xml · nonDerivative · entry 1 Sank Leonard · CIK 0001416089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 00:00 UTC |
KIDRON NADAVDirector · President and CEO
|
Tax withholdingCommon Stock | 12,631 | $8.36 | $105,595.16 |
DisclosureSEC source: 0001209191-22-043768 · doc4.xml · nonDerivative · entry 3 KIDRON NADAV · CIK 0001351779 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,078,098 F3 · shares: Payment of tax liability by withholding securities related to the 34,000 shares of Common Stock granted on July 28, 2022. Read SEC document |
| July 28, 2022 Filed Aug 2, 2022 00:01 UTC |
Rozov YadinDirector
|
GrantCommon Stock | 12,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-043772 · doc4.xml · nonDerivative · entry 1 Rozov Yadin · CIK 0001921268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,500 F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 4,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. Read SEC document |
| July 28, 2022 Filed Aug 2, 2022 00:00 UTC |
Derovan NetanelChief Legal Officer
|
GrantCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-043770 · doc4.xml · nonDerivative · entry 1 Derovan Netanel · CIK 0001901330 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 10,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. Read SEC document |
| July 28, 2022 Filed Aug 2, 2022 00:01 UTC |
Mayer ArieDirector
|
GrantCommon Stock | 12,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-043771 · doc4.xml · nonDerivative · entry 1 Mayer Arie · CIK 0001796583 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 4,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. Read SEC document |
| July 28, 2022 Filed Aug 2, 2022 00:00 UTC |
Kidron MiriamDirector · Chief Scientific Officer
|
GrantCommon Stock | 84,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-043769 · doc4.xml · nonDerivative · entry 2 Kidron Miriam · CIK 0001409232 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,666 F2 · price: Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 28,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. Read SEC document |
| July 28, 2022 Filed Aug 2, 2022 00:00 UTC |
Kidron MiriamDirector · Chief Scientific Officer
|
GrantCommon Stock | 34,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-043769 · doc4.xml · nonDerivative · entry 1 Kidron Miriam · CIK 0001409232 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,666 F1 · price: Represents Common Stock granted by the Issuer that vested on August 1, 2022. Read SEC document |
| July 28, 2022 Filed Aug 2, 2022 00:00 UTC |
Hexter JoshuaCOO & CBO
|
GrantCommon Stock | 42,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-043767 · doc4.xml · nonDerivative · entry 1 Hexter Joshua · CIK 0001573235 · COO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,333 F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 14,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. Read SEC document |
| July 28, 2022 Filed Aug 2, 2022 00:00 UTC |
KIDRON NADAVDirector · President and CEO
|
GrantCommon Stock | 126,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-043768 · doc4.xml · nonDerivative · entry 2 KIDRON NADAV · CIK 0001351779 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,090,729 F2 · price: Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 42,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. Read SEC document |
| July 28, 2022 Filed Aug 2, 2022 00:00 UTC |
KIDRON NADAVDirector · President and CEO
|
GrantCommon Stock | 34,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-043768 · doc4.xml · nonDerivative · entry 1 KIDRON NADAV · CIK 0001351779 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 964,729 F1 · price: Represents Common Stock granted by the Issuer that vested on August 1, 2022. Read SEC document |
| July 28, 2022 Filed Aug 2, 2022 00:00 UTC |
Sank LeonardDirector
|
GrantCommon Stock | 12,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-043766 · doc4.xml · nonDerivative · entry 1 Sank Leonard · CIK 0001416089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 4,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. F2 · balance_after: The reporting person previously reported and disclaimed beneficial ownership over 138,889 shares of common stock owned by a company wholly owned by a trust of which the reporting person was previously a trustee. The reporting person resigned as a trustee of such trust, effective February 3, 2022. Read SEC document |
| July 28, 2022 Filed Aug 2, 2022 00:00 UTC |
Rabinowitz MichaelChief Commercial Officer
|
GrantCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-043764 · doc4.xml · nonDerivative · entry 1 Rabinowitz Michael · CIK 0001876182 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,468 F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 10,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. Read SEC document |
| July 28, 2022 Filed Aug 2, 2022 00:00 UTC |
Silberman DavidChief Financial Officer
|
GrantCommon Stock | 39,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-043765 · doc4.xml · nonDerivative · entry 1 Silberman David · CIK 0001867998 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,000 F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 13,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.